PDS Biotechnology
PDSB
PDSB
59 hedge funds and large institutions have $101M invested in PDS Biotechnology in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
22% more capital invested
Capital invested by funds: $82.4M → $101M (+$18.2M)
1.78% more ownership
Funds ownership: 21.98% → 23.76% (+1.8%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
59
Holding in Top 10
–
Calls
$4.56M
Puts
$3.03M
Top Buyers
| 1 | +$7.13M | |
| 2 | +$4.91M | |
| 3 | +$4.64M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.95M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$2.55M | |
| 3 | -$1.89M | |
| 4 |
Renaissance Technologies
New York
|
-$1.34M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1M |